a vector vaccine, a dna rna vaccine, in this regard, we work closely with the institute of biophysics and cell engineering of the national academy of sciences of belarus and , the main two directions. this is the development of vector vaccines - this is a vaccine that is being developed against viruses that are difficult to accumulate and difficult to culture. in particular. it's a virus respiratory syncytial infections and the second direction is a marker vaccine, when a specific marker. we insert a virus into the genome and such vaccines allow us to distinguish the vaccinated animal. here are those who have been ill, this is dna yes, but no, this is not a dna vaccine. this is a marker vaccine, they are being developed. mainly for diseases such as infectious rhinotracheitis, classical plague, swine fever, travel sickness virus. as for the dna of vaccines, i would like to note that not always from all technologies that work in medicine, they acceptable for veterinary use. that is, for example, as the covid-19 pandemic showed, the developed dna vaccine should be stored under conditions e, at -80 °. that is